In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: A Korean multicenter study

Annals of Laboratory Medicine

Volumn 35, Issue 5, 2015, Pages 523-530

  Lee, Yangsoon ^a   Hong, Sung Kuk ^b   Choi, Sung Hak ^c   Im, Weonbin ^c   Yong, Dongeun ^b   Lee, Kyungwon ^b  

^a Hanyang University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Dong A ST Co Ltd   (South Korea)

Author keywords

Gram positive bacteria; Infection; Pneumonia; Skin; Soft tissue; Tedizolid

Indexed keywords

ANTIINFECTIVE AGENT; LINEZOLID; ORGANOPHOSPHATE; OXAZOLE DERIVATIVE; TEDIZOLID;

ASIAN CONTINENTAL ANCESTRY GROUP; DRUG EFFECTS; GRAM POSITIVE BACTERIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMONIA; SKIN; SKIN DISEASES; SOUTH KOREA;

ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; LINEZOLID; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; ORGANOPHOSPHATES; OXAZOLES; PNEUMONIA; REPUBLIC OF KOREA; SKIN; SKIN DISEASES;

EID: 84942255217     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2015.35.5.523     Document Type: Article

References (15)

1. Rajan S. Skin and soft-tissue infections: classifying and treating a spectrum. Cleve Clin J Med 2012;79:57-66.
2. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(S5): S378-85.
3. Mendes RE, Flamm RK, Hogan PA, Ross JE, Jones RN. Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States. Antimicrob Agents Chemother 2014;58:1243-7.
4. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 2013;68:4-11.
5. Moravvej Z, Estaji F, Askari E, Solhjou K, Naderi Nasab M, Saadat S. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains. Int J Antimicrob Agents 2013;42:370-1.
6. Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J Antimicrob Chemother 2012;67:167-9.
7. Shaw KJ, Poppe S, Schaadt R, Brown-Driver V, Finn J, Pillar CM, et al. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob Agents Chemother 2008;52:4442-7.
8. Moellering RC Jr. Tedizolid: a novel oxazolidinone for Gram-positive infections. Clin Infect Dis 2014;58(S1):S1-3.
9. Kisgen JJ, Mansour H, Unger NR, Childs LM. Tedizolid: a new oxazolidinone antimicrobial. Am J Health Syst Pharm 2014;71:621-33.
10. Yum JH, Choi SH, Yong D, Chong Y, Im WB, Rhee DK, et al. Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. Antimicrob Agents Chemother 2010;54:5381-6.
11. US Food and Drug Administration. Guidance for industry: acute bacterial skin and skin structure infections: developing drugs for treatment. US Food and Drug Administration, 2010.
12. Goldstein EJ, Solomkin JS, Citron DM, Alder JD. Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. Clin Infect Dis 2011;53:1074-80.
13. Brook I, Wexler HM, Goldstein EJ. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev 2013;26:526-46.
14. Sivextro (tedizolid) Prescribing information. Lexington, MA: Cubist Pharmaceuticals, 2014.
15. Thomson KS and Goering RV. Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins. Antimicrob Agents Chemother 2013;57: 2892-5.